Product Information
CABTREO 1.2%-0.15%-3.15% GEL is a brand product labeled by Bausch Health US LLC, priced at $18.2075 per GM under NDC 00187000625. Its NADAC has been published 68 times since Jun 19, 2024.
FDA first approved this application on Oct 20, 2023.
Strength
1.5; 31; 12 mg/g; mg/g; mg/g
Manufacturer
Bausch Health US LLCNDC
00187000625
Classification
Brand
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/17/2025
Active Ingredients
ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA216632FDA Approved
10/20/2023
On Market Since
10/20/2023
Pharmacological Classes
Price Statistics
The NADAC for CABTREO 1.2%-0.15%-3.15% GEL has been published 68 times since Jun 19, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.2075 per GM |
|---|---|
| All-time high | $18.2075 (Oct 1, 2025) |
| All-time low | $18.1256 (Jun 19, 2024) |
| 52-week high | $18.2075 |
| 52-week low | $18.2006 |
| Median price | $18.1713 |
| Average price | $18.1707 |
| Largest weekly change | +0.3% (Jul 17, 2024) |
| Weeks tracked | 68 |
| Tracking since | Jun 19, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+0.0%
3Y
N/A
5Y
N/A
All
+0.5%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clindamycin phosphate/benzoyl peroxide/adapalene market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CABTREO 1.2%-0.15%-3.15% GEL?
The current National Average Drug Acquisition Cost (NADAC) for CABTREO 1.2%-0.15%-3.15% GEL, manufactured by Bausch Health US LLC, is $18.2075 per GM (NDC 00187000625), effective Oct 1, 2025.
How has the price of CABTREO 1.2%-0.15%-3.15% GEL changed over time?
Over the history we have for it, the NADAC for CABTREO 1.2%-0.15%-3.15% GEL has held within roughly two percent of its current level. It has been tracked across 68 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for CABTREO 1.2%-0.15%-3.15% GEL?
Since Jun 19, 2024, the NADAC for CABTREO 1.2%-0.15%-3.15% GEL has ranged from a low of $18.1256 (Jun 19, 2024) to a high of $18.2075 (Oct 1, 2025), with a median of $18.1713 per GM.
Are there cheaper alternatives to CABTREO 1.2%-0.15%-3.15% GEL?
No other NADAC-published product currently shares the active ingredient and strength of CABTREO 1.2%-0.15%-3.15% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CABTREO 1.2%-0.15%-3.15% GEL?
CABTREO 1.2%-0.15%-3.15% GEL (NDC 00187000625) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.